Announce Date | 07/24/2024 |
EPS Normalized Actual | $0.67 (Beat by $0.098) |
EPS GAAP Actual | $0.67 (Beat by $0.098) |
Revenue Actual | $1.1564B |
Revenue Surprise | Beat by $1156.4M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.56198 |
EPS GAAP Estimate | $0.56198 |
Revenue Estimate | $1.931747698B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 5.87 | 13.14 | 5.73587 | 6.11984 | 2 |
Dec 2027 | 4.83 | 15.97 | 4.71963 | 5.03558 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.02 | 0.02 | 1.1564B | 5.02% | 1156.4M |
FQ4 2021 (Dec 2021) | 0.06 | 0.06 | 1.4105B | 7.43% | 1410.5M |
FQ3 2021 (Sep 2021) | 0.16 | 0.16 | 1.2289B | 5.44% | 1228.9M |
FQ2 2021 (Jun 2021) | 0.03 | 0.03 | 1.2603B | 20.2% | 1260.3M |
FQ1 2021 (Mar 2021) | 0.09 | 0.09 | 1.0984B | 18.31% | 1098.4M |
FQ4 2020 (Dec 2020) | 0.23 | 0.23 | 1.3057B | 100% | 1305.7M |
FQ3 2020 (Sep 2020) | -0.05 | -0.05 | 1.162B | 100% | 1162M |
FQ2 2020 (Jun 2020) | 0.08 | 0.08 | 1.0057B | 100% | 1005.7M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
0.56198
Consensus Revenue Estimates
1.931747698B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.81405 | -- | 0.77962 | 0.84873 | 3 |
FQ3 2025 (Jul 2025) | 0.74611 | -- | 0.71456 | 0.7779 | 3 |
FQ2 2025 (Jun 2025) | 0.66213 | -- | 0.64442 | 0.67733 | 3 |
FQ1 2025 (Mar 2025) | 0.46181 | -- | 0.44946 | 0.47241 | 3 |
FQ4 2024 (Oct 2024) | 0.62306 | -- | 0.56465 | 0.67174 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 2.16B | -- | 2.09B | 2.23B | 2 |
FQ3 2025 (Jul 2025) | 2.13B | -- | 2.06B | 2.2B | 2 |
FQ2 2025 (Jun 2025) | 2.03B | -- | 1.99B | 2.07B | 2 |
FQ1 2025 (Mar 2025) | 1.78B | -- | 1.75B | 1.82B | 2 |
FQ4 2024 (Oct 2024) | 1.97B | -- | 1.88B | 2.07B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.02 | 0.02 | 100% | |
FQ4 2021 (Dec 2021) | 0.06 | 0.06 | 100% | |
FQ3 2021 (Sep 2021) | 0.16 | 0.16 | 100% | |
FQ2 2021 (Jun 2021) | 0.03 | 0.03 | 100% | |
FQ1 2021 (Mar 2021) | 0.09 | 0.09 | 100% | |
FQ4 2020 (Dec 2020) | 0.23 | 0.23 | 100% | |
FQ3 2020 (Sep 2020) | -0.05 | -0.05 | 100% | |
FQ2 2020 (Jun 2020) | 0.08 | 0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $1.16B | $1156.4M | 100% |
FQ4 2021 (Dec 2021) | $0B | $1.41B | $1410.5M | 100% |
FQ3 2021 (Sep 2021) | $0B | $1.23B | $1228.9M | 100% |
FQ2 2021 (Jun 2021) | $0B | $1.26B | $1260.3M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.1B | $1098.4M | 100% |
FQ4 2020 (Dec 2020) | $0B | $1.31B | $1305.7M | 100% |
FQ3 2020 (Sep 2020) | $0B | $1.16B | $1162M | 100% |
FQ2 2020 (Jun 2020) | $0B | $1.01B | $1005.7M | 100% |